These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 18778118)

  • 21. Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
    Wang J; Zhou M; Xu JY; Zhou RF; Chen B; Wan Y
    JAMA Netw Open; 2020 Oct; 3(10):e2017652. PubMed ID: 33030550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
    Bhatti Z; Shaukat A; Almyroudis NG; Segal BH
    Mycopathologia; 2006 Jul; 162(1):1-15. PubMed ID: 16830186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guidelines for the management of deep mycosis in neutropenic patients].
    Yoshida M
    Nihon Ishinkin Gakkai Zasshi; 2004; 45(4):209-15. PubMed ID: 15550917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
    Salavert-Lletí M; Zaragoza-Crespo R
    Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B.
    Lacerda JF; Oliveira CM
    Clin Drug Investig; 2013 Feb; 33 Suppl 1():S5-14. PubMed ID: 23381977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of invasive mycoses in hematology patients: current approaches.
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):5-14. PubMed ID: 15651177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment.
    Herbrecht R; Neuville S; Letscher-Bru V; Natarajan-Amé S; Lortholary O
    Drugs Aging; 2000 Nov; 17(5):339-51. PubMed ID: 11190415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fungal infections in leukemia patients: how do we prevent and treat them?
    Leventakos K; Lewis RE; Kontoyiannis DP
    Clin Infect Dis; 2010 Feb; 50(3):405-15. PubMed ID: 20047485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posaconazole: a new antifungal weapon.
    Aperis G; Alivanis P
    Rev Recent Clin Trials; 2011 Sep; 6(3):204-19. PubMed ID: 21682687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal prophylaxis during neutropenia and immunodeficiency.
    Lortholary O; Dupont B
    Clin Microbiol Rev; 1997 Jul; 10(3):477-504. PubMed ID: 9227863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients].
    Groll AH; Ritter J
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S37-66. PubMed ID: 16288352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
    Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
    Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
    Gomes MZ; Mulanovich VE; Jiang Y; Lewis RE; Kontoyiannis DP
    Antimicrob Agents Chemother; 2014; 58(2):865-73. PubMed ID: 24277033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
    Rogers TR; Frost S
    Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.
    Maximova N; Schillani G; Simeone R; Maestro A; Zanon D
    Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.